Abstract
Psychiatric syndromes are common in all organ transplant patients, both candidates and recipients, with etiological contributions including biological (e.g. organ failure), social (e.g. disruption of support system), and iatrogenic factors (e.g. medication side-effects). Of course, the types, frequency, and causation of psychiatric syndromes vary both with the type of transplant and stage of treatment (disease pre-transplant, early post-operative, chronic maintenance treatment). In this chapter, we will focus on psychiatric syndromes primarily due to biological (“organic”) factors associated with organ failure, transplant surgery, and immunosuppressant drugs, and psychopharmacologic treatment of these syndromes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abram, H.S., Moore, G.L., & Westervelt, F.B. Jr. (1971). Suicidal behavior in chronic dialysis patients.American Journal of Psychiatry, 127, 1199–1204.
American Psychiatric Association. (1999). Practice guideline for the treatment of patients with delirium.American Journal of Psychiatry, 156(Suppl. 5), 1–20.
Andrykowski, M.A. (1994). Psychiatric and psychosocial aspects of bone marrow transplantation.Psychosomatics, 35, 13–24.
Aronoff, G.R., Berns, J.S., Brier, M.E., Golper T.A., Morrison, G., Singer, I, Swan, S.K., & Bennett, W.M., (1999).Drug prescribing in renal failure: Dosage guidelines for adults(4thed.). Philadelphia: American College of Physicians.
Beliles, K.E. (2000). Psychopharmacokinetics in the medically ill. In A. Stoudemire, B.S. Fogel, & D.B. Greenberg (eds.),Psychiatric care of the medical patient (2 nd ed.)(pp. 373–394). New York: Oxford University Press.
Beydoun, A., Uthman, B.M., & Sackellares, J.C. (1995). Gabapentin: Pharmacokinetics, efficacy, and safety. Clinical Neuropharmacology, 18, 469–481.
Bornstein, R.A., Starling, R.C., Myerowitz, P.D., & Haas, G.J. (1995). Neuropsychological function in patients with end-stage heart failure before and after cardiac transplantation.Acta Neurologica Scandinavica, 91, 260–265.
Branch, R.A. (1987). Is there increased cerebral sensitivity to benzodiazepines in chronic liver failure?Hepatology, 7, 773–776.
Brown, T.M., & Brown, R.L.S. (1995). Neuropsychiatric consequences of renal failure.Psychosomatics, 36, 244–253.
Brown, T.M., Stoudemire, A., Fogel, B.S., & Moran, M.G. (2000). Psychopharmacology in the medical patient. In A. Stoudemire, B.S. Fogel, & D.B. Greenberg (eds.),Psychiatric care of the medical patient (2nd ed.)(pp. 329–372). New York: Oxford University Press.
Buckley, N.A., & Sanders, P. (2000). Cardiovascular adverse effects of antipsychotic drugs.Drug Safety, 23, 215–228.
Carone, M., Bertolotti, G., Anchisi, F., Zotti, A.M., Donner, C.F., & Jones, P.W. (1999). Analysis of factors that characterize health impairment in patients with chronic respiratory failure. Quality of Life in Chronic Respiratory Failure Group.European Respiratory Journal, 13, 1293–1300.
Collis, I., & Lloyd, G. (1992). Psychiatric aspects of liver disease.British Journal of Psychiatry, 161, 12–22.
Craven, J.L. (1990a). Postoperative organic mental syndromes in lung transplant recipients.Journal of Heart Transplantation, 9, 129–132.
Craven, J. (1990b). Psychiatric aspects of lung transplant The Toronto Lung Transplant Group.Canadian Journal of Psychiatry, 35, 759–764.
Craven, J.L., Bright, J., & Dear, C.L. (1990). Psychiatric, psychosocial, and rehabilitative aspects of lung transplantation.Clinics in Chest Medicine, 11, 247–257.
Craven, J.L., & Sutherland, A. (1991). Buspirone for anxiety disorders in patients with severe lung disease.Lancet, 338, 249.
DasGupta, K., & Jefferson, J.W., (1990). The use of lithium in the medically ill.General Hospital Psychiatry, 12, 83–97.
De Ponti, F., Poluzzi, E., & Montanaro, N. (2000). QT-interval prolongation by non-cardiac drugs: Lessons to be learned from recent experience.European Journal of Clinical Pharmacology, 56, 1–18.
Dent, M., Yernlt, J., & DeCoster, A. (1975). A double-blind comparison of the respiratory effects of parenteral lorazepam and diazepam in patients with COPD.Current Medical Research Opinion, 2, 611–615.
Dew, M.A., Roth, L.H., Schulberg, H.C., Simmons, R.G., Kormos, R.L., Trezpacz, P.T., & Griffith, B.P. (1996). Prevalence and predictors of depression and anxiety-related disorders during the year after heart transplantation.General Hospital Psychiatry, 18 (Suppl. 6), 48–61.
Di Salvo, T.G., & O’Gara, P.T. (1995). Torsade de Pointes caused by high-dose intravenous haloperidol in cardiac patients.Clinical Cardiology, 18, 285–290.
Endicott, J. (1984). Measurement of depression in patients with cancer.Cancer, 53 (Suppl. 10), 2243–2249.
Feder, R. (1991). Bradycardia and syncope induced by fluoxetine [Letter to the Editor].Journal of Clinical Psychiatry, 52, 139.
Frasure-Smith, N., & Lesperance, F. (1993). Depression following myocardial infarction: Impact on 6-month survival.Journal of the American Medical Association, 271, 1819–1825.
Freeman, A.M. 3rd, Folks, D.G., Sokol, R.S., & Fahs, J.J. (1988). Cardiac transplantation: Clinical correlates of psychiatric outcome.Psychosomatics, 29, 47–54.
Fricchione, G.L., Olson, L.C., & Vlay, S.C. (1989). Psychiatric syndromes in patients with the automatic internal cardioverter defibrillator: Anxiety, psychological dependence, abuse, and withdrawal.American Heart Journal, 117, 1411–1414.
Gajwani, P., Pozuelo, L., & Tesar, G.E. (2000). QT interval prolongation associated with quetiapine (Seroquel) overdose.Psychosomatics, 41, 63–65.
Gardner, D.M., Milliken, J., & Dursun, S.M. (1999). Olanzapine overdose [Letter to the Editor].American Journal of Psychiatry, 156, 1118–1119.
Garner, S., Eldridge, F., Wagner, P., & Dowell R.T. (1989). Buspirone: An anxiolytic drug that stimulates respiration.American Review of Respiratory Disease, 139, 945–950.
Ghabrial, H., Desmond, P.V., Watson, K.J., Gijsbers, A.J., Harman, P.J., Breen, K.J., & Mashford, M.L. (1986). The effects of age and chronic liver disease on the elimination of temazepam.European Journal of Clinical Pharmacology, 30, 93–97.
Gitlin, M.J. (1993). Lithium-induced renal insufficiency.Journal of Clinical Psychopharmacology, 14, 435–436.
Gross, M.L., Sweny, P., Pearson, R.M., Kennedy, J., Fernando, O.N., & Moorhead, J.F. (1982). Rejection encephalopathy: An acute neurological syndrome complicating renal transplantation.Journal of the Neurological Sciences, 56, 23–34.
Guarino, M., Stracciari, A., Pazzaglia, P., Sterzi, R., Santilli, I. & Donato, F. (1996). Neurological complications of liver transplantation.Journal of Neurology, 243, 137–142.
Haenel, T., Brunner, F., & Battegay, R. (1980). Renal dialysis and suicide: Occurrence in Switzerland and in Europe.Comprehensive Psychiatry, 21, 140–145.
Hammond, J.B., & Ahmad, F. (1998). Hepatic encephalopathy and the role of antibenzodiazepines.American Journal of Therapeutics, 5, 33–36.
Hamner, M., Hunt, N., Gee, J., Garrell, R., & Monroe, R. (1999). PTSD and automatic implantable cardioverter defibrillators.Psychosomatics, 40, 82–85.
Hening, W., Allen, R., Earley, A.R., Kushida, C., Picchietti, D., & Silber, M. (1999). The treatment of restless legs syndrome and periodic limb movement disorder: An American Academy of Sleep Medicine review.Sleep, 22, 970–999.
Hotson, J.R., & Enzmann, D.R. (1988). Neurologic complication of cardiac transplantation.Neurologic Clinics, 6, 349–365.
Hulisz, D.T., Dasa, S.L., Black, L.D., & Heiselman, D.E. (1994). Complete heart block and torsade de pointes associated with thioridazine poisoning.Pharmacotherapy, 14, 239–245.
Hunt, N., & Stern, T.A. (1995). The association between intravenous haloperidol and Torsades de Pointes: Three cases and a literature review.Psychosomatics, 36, 541–549.
Jackson, T., Ditmanson, L., & Phibbs, B. (1997). Torsade de pointes and low-dose oral haloperidol.Archives of Internal Medicine, 157, 2013–2015.
Kahn, J.P., Drusin, R.E., & Klein, D.F. (1987). Idiopathic cardiomyopathy and panic disorder: Clinical association in cardiac transplant candidates.American Journal of Psychiatry, 144, 1327–1330.
Kellner, C.H., Monroe, R.R., Burns, C., Bernstein, H.J., & Crumbley, A.J., (1991). Electroconvulsive therapy in a patient with a heart transplant [Letter to the Editor].New England Journal of Medicine, 325, 663.
Kershner, P., & Wang-Cheng, R. (1989). Psychiatric side effects of steroid therapy.Psychosomatics, 30, 135–139.
Klein, D.F. (1993). False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis.Archives of General Psychiatry, 50, 306–317.
Klingebiel, T., & Schlegel, P.G. (1998). GVHD: Overview on pathophysiology, incidence, clinical and biological features.Bone Marrow Transplantation, 21 (Suppl. 2), S45–S49.
Koecheler, J.A., Canafax, D.M., Simmons, R.L., & Najarian, J.S. (1986). Lithium dosing in renal allograft recipients with changing renal function.Drug Intelligence and Clinical Pharmacy, 20, 623–624.
Krahenbuhl, S., Sauter, B., Kupferschmidt, H., Krause, M., Wyss, P.A., & Meier, P.J. (1995). Case report: Reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication.American Journal of Medical Sciences, 309, 315–316.
Krahn, L.E., & Richardson, J.W. (2000). Sleep disorders in the medically ill. In A. Stoudemire, B.S. Fogel, & D.B. Greenberg (eds.),Psychiatric care of the medical patient (2nd ed.)(pp. 683–697). New York: Oxford University Press.
Leipzig, R.M. (1990). Psychopharmacology in patients with hepatic and gastrointestinal disease.International Journal of Psychiatry in Medicine, 20, 109–139.
Leo, R.J. (1996). Movement disorders associated with the serotonin selective reuptake inhibitors.Journal of Clinical Psychiatry, 57, 449–454.
Leo, R.J., Kreeger, J.L., & Kim, K.Y. (1996). Cardiomyopathy associated with clozapine.Annals of Pharmacotherapy, 30, 603–605.
Lerner, D.M., Stoudemire, A., & Rosenstein, D.L. (1999). Neuropsychiatric toxicity associated with cytokine therapies.Psychosomatics, 40, 428–435.
Lesko, L.M. (1991a). Bone marrow transplantation. In J.C. Holland & J.H. Rowland (eds.),Psycho-oncology(pp. 163–173). New York: Oxford University Press.
Lesko, L.M. (1991b). Protected environments. In J.C. Holland & J.H. Rowland (eds.),Psycho-oncology(pp. 174–179). New York: Oxford University Press.
Levenson, J.L., & Dwight, M. (2000). Cardiology. In A. Stoudemire, B.S. Fogel, & D.B. Greenberg (eds.),Psychiatric care of the medical patient (2nd ed.)(pp. 717–731). New York: Oxford University Press.
Levenson, J.L., & Olbrisch, M.E. (1993). Psychiatric aspects of heart transplantation.Psychosomatics, 34, 114–123.
Levy, N.B. (2000). Psychiatric considerations in the primary medical care of the patient with renal failure.Advances in Renal Replacement Therapy, 7, 231–238.
Lishman, W.A. (1997). Endocrine diseases and metabolic disorders. InOrganic psychiatry: The psychological consequences of cerebral disorder (3rd ed). Oxford: Blackwell Science.
Low, R.A. Jr., Fuller, M.A., & Popli, A. (1998). Clozapine induced atrial fibrillation [Letter to the Editor].Journal of Clinical Psychopharmacology, 18, 170.
Mai, F.M., McKenzie, F.N., & Kostuk, M.J. (1986). Psychiatric aspects of heart transplantation: Preoperative evaluation and postoperative sequelae.British Medical Journal (Clinical Research Edition), 292, 311–313.
Mai, F.M., McKenzie, F.N., & Kostuk, W.J. (1990). Psychosocial adjustment and quality of life following heart transplantation.Canadian Journal of Psychiatry, 35, 223–227.
Maricle, R.A., Hosenpud, J.D., Norman, D.J., Woodbury, A., Pantley, G.A., Cobanoglu, A.M., & Starr, A. (1989). Depression in patients being evaluated for heart transplantation.General Hospital Psychiatry, 11, 418–424.
Masand, P., Pickett, P., & Murray, G.B. (1991). Psychostimulants for secondary depression in medical illness.Psychosomatics, 32, 203–208.
Masand, P.S., & Tesar, G.E. (1996). Use of stimulants in the medically ill.Psychiatric Clinics of North America, 19, 515–547.
Mendelson, W.B., Maczaj, M., & Holt, J. (1991). Buspirone administration to sleep apnea patients [Letter to the Editor].Journal of Clinical Psychopharmacology, 11, 71–72.
Mitchell-Heggs, P., Murphy, K., & Minte, K. (1980). Diazepam in the treatment of dyspnea in the “pink puffer” syndrome.Quarterly Journal of Medicine, 49, 9–20.
Montero, C.G., & Martinez, A.J. (1986). Neuropathology of heart transplantation: 23 cases.Neurology, 36, 1149–1154.
Neff, M.S., Leggat, J.E. Jr., & Port, F.K. (1999). To be or not to be: The decision to withdraw or be withdrawn from dialysis.American Journal of Kidney Disease, 33, 601–606.
Nelson, J.C., Kennedy, J.S., Pollock, B.G., Laghrissi-Thode, F., Narayan, M., Nobler, M.S., Robin, D.W., Gergel, I., McCafferty, J., & Roose, S. (1999). Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease.American Journal of Psychiatry, 156, 1024–1028.
O’Donnell, K., Chung, J.Y. (1997). The diagnosis of major depression in end-stage renal disease.Psychotherapy and Psychosomatics, 66, 38–43.
Ochs, H.R., Greenblatt, B.J., Verburg-Ochs, B., & Amtlas, R. (1986). Clonazepam clearance on altered end cirrhosis.American Journal of Gastroenterology, 81, 80–84.
Oldenburg, B., Martin, A., Greenwood., J., Bernstnein, L., & Allan, R. (1995). A controlled trial of a behavioral and educational intervention following coronary artery bypass surgery.Journal of Cardiopulmonary Rehabilitation, 15, 39–46.
Olyaei, A.J., deMattos, A.M., Norman, D.J., & Bennett, W.M. (1998). Interaction between tacrolimus and nefazodone in a stable renal transplant recipientPharmacotherapy, 18, 1356–1359.
Plutchik, L., Snyder, S., Drooker, M., Chodoff, L., & Cheiner, P. (1998). Methylphenidate in post liver transplant patients.Psychosomatics, 39, 118–123.
Ravin, D.S., & Levenson, J.W. (1997). Fatal cardiac event following initiation of risperidone therapy.Annals of Pharmacotherapy, 31, 867–870.
Reither, A.M., Smith, S.L., Lewison, B.J., Cotsonis, G.A., & Epstein, C.M. (1992). Quality-of-life changes and psychiatric and neurocognitive outcome after heart and liver transplantation.Transplantation, 54, 444–450.
Robinson, M.J., & Levenson, J.L. (2000). The use of psychotropics in the medically ill.Current Psychiatry Reports, 2, 247–255.
Roose, S.P. (2000). Considerations for the use of antidepressants in patients with cardiovascular disease.American Heart Journal, 140 (Suppl. 4), 84–88.
Roose, S.P., Dalack, G.W., Glassman, A.H., Woodring, S., Walsh, B.T., & Giardina, E.G. (1991). Cardiovascular effects of bupropion in depressed patients with heart disease.American Journal of Psychiatry, 148, 512–516.
Roose, S.P., Glassman, A.H., Attia, E., Woodring, S., Giardina, E.G., & Bigger, J.T. Jr. (1998). Cardiovascular effects of fluoxetine in depressed patients with heart disease.American Journal of Psychiatry, 155, 660–665.
Roose, S.P., Glassman, A.H., Giardina, E.G., Johnson, L.L., Walsh, B.T., & Bigger, J.T. Jr. (1987). Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure.Journal of Clinical Psychopharmacology, 7, 247–251.
Roose, S.P., & Spatz, E. (1999). Treatment of depression in patients with heart disease.Journal of Clinical Psychiatry, 60 (Suppl. 20), 34–37.
Schall, R.R., Petrucci, R.J., Brozena, S.C., Cavarocchi, N.C., & Jessup, M. (1989). Cognitive function in patients with symptomatic dilated cardiomyopathy before and after transplantation.Journal of the American College of Cardiology, 14, 1666–1672.
Schroeder, J.S. (1994). Indications for cardiac transplantation.Heart Disease and Stroke, 3, 345–349.
Sears, S.F., Todaro, J.F., Urizar, G., Lewis, T.S., Sirois, B., Wallace, R., Sotile, W., Curtis, A.B., & Conti, J.B. (2000). Assessing the psychosocial impact of the ICD: A national survey of implantable cardioverter defibrillator health care providers.Pacing and Clinical Electrophysiology, 23, 939–945.
Shapiro, P.A., Lesperance, F., Frasure-Smith, N., O’Connor, C.M., Baker, B., Jiang, J.W., Dorian, P., Harrison, W., & Glassman, A.H. (1999). An open-label preliminary trial of sertraline for the treatment of major depression after acute myocardial infarction (the SADHAT trial).American Heart Journal, 137, 1100–1106.
Showalter, P.E., Young, SA., Bilello, J. F., Schafer, T.R., & Shaver, T.R. (1993). Electroconvulsive therapy for depression in a liver transplant patient [Letter to the Editor].Psychosomatics, 34, 537.
Sipahimalani, A., & Masand, P.S. (1997). Use of risperidone in delirium: Case reports.Annals of Clinical Psychiatry, 9, 105–107.
Sipahimalani, A., & Masand, P.S. (1998). Olanzapine in the treatment of delirium.Psychosomatics, 39, 422–430.
Sloan, R.P., Shapiro, P.A., & Gorman, J.M. (1990). Psychophysiological reactivity in cardiac transplant recipients.Psychophysiology, 27, 187–194.
Smith, L.W., & Dimsdale, J.E. (1989). Postcardiotomy delirium: Conclusions after 25 years?American Journal of Psychiatry, 146, 452–458.
Steen, S., Amaha, K., & Martinez, L. (1966). Effect of oxazepam on respiratory response to carbon dioxide.Anesthesia and Analgesia, 45, 455–458.
Surman, O.S. (1994). Psychiatric aspects of liver transplantation.Psychosomatics, 35, 297–307.
Tarter, R.E., Hegedus, A.M., Van Theil, D.H., & Schade, R.R. (1985). Portal-systemic encephalopathy: Neuropsychiatric manifestations.International Journal of Psychiatry in Medicine, 15, 265–275.
Thompson, D., & DiMartini, A., (1999). Nonenteral routes of administration for psychiatric medications. A literature review.Psychosomatics, 40, 185–92.
Thompson, W.L. (2000). Pulmonary Disease. In A. Stoudemire, B.S. Fogel, & D.B. Greenberg (eds.),Psychiatric care of the medical patient (2nd ed.)(pp. 758–774). New York: Oxford University Press.
Troy, S.M, Schultz, R.W., Parker, V.D., Chiang, S.T, & Blum, R.A. (1994). The effect of renal disease on the disposition of venlafaxine.Clinical Pharmacology and Therapeutics, 56, 14–21.
Trzepacz, P.T., Brenner, R., & Van Thiel, D.H. (1989). A psychiatric study of 247 liver transplantation candidates.Psychosomatics, 30, 147–153.
Trzepacz, P.T., DiMartini, A., & Tringali, R.D. (1993). Psychopharmacologic issues in organ transplantation. Part 2: Psychopharmacologic medications.Psychosomatics, 34, 290–298.
Trzepacz, P.T., Levenson, J. L., & Tringali, R. A, (1991). Psychopharmacology and neuropsychiatric syndromes in organ transplantation.General Hospital Psychiatry, 13, 233–245.
Trzepacz, P.T., Maue, F.R., Coffman, G., & Van Theil, D.H. (1986–1987). Neuropsychiatric assessment of liver transplantation candidates: Delirium and other psychiatric disorders.International Journal of Psychiatry in Medicine, 16, 101–111.
Varma, S., & Achan, K. (1999). Dysrhythmia associated with clozapine [Letter to the Editor].Australia and New Zealand Journal of Psychiatry, 33, 119–119.
Vella, J.P., & Sayegh, M.H. (1998). Interactions between cyclosporine and newer antidepressant medications.American Journal of Kidney Diseases, 31, 320–323.
Vincent, H.H., Wenting, G.J., Schalekamp, M.A., Jeekel, J., & Weimar, W. (1987). Impaired fractional excretion of lithium: A very early marker of cyclosporine nephrotoxicity.Transplantation Proceedings, 79, 4147–4148.
Wilkinson, G.R. (1978). The effects of liver disease and aging on the disposition of the diazepam, chlordiazepoxide, oxazepam and lorazepam in man.Acta Psychiatria Scandinavia , 274 (Suppl.), 56–74.
Wyszynski, A., & Wyszynski, B. (1996). The cardiovascular patient. In A. Wyszynski & B. Wyszynski (eds.),A case approach to medical-psychiatric practice(pp. 1–63). Washington, DC: American Psychiatric Press.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Robinson, M.J., Levenson, J.L. (2001). Psychopharmacology in Transplantation. In: Rodrigue, J.R. (eds) Biopsychosocial Perspectives on Transplantation. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1333-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1333-9_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5502-1
Online ISBN: 978-1-4615-1333-9
eBook Packages: Springer Book Archive